CORVEL CORP – 10-Q – Management's Discussion and Analysis of Financial Condition and Results of Operations

This report may include certain forward-looking statements, within the meaning
of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended, including (without limitation)
statements with respect to anticipated future operating and financial
performance, including the impact of COVID-19, growth and acquisition
opportunities and other similar forecasts and statements of expectation. Words
such as "expects," "anticipates," "intends," "plans," "predicts," "believes,"
"seeks," "estimates," "potential," "continue," "strive," "ongoing," "may,"
"will," "would," "could," "should," and variations of these words and similar
expressions, are intended to identify these forward-looking statements.
Forward-looking statements made by the Company and its management are based on
estimates, projections, beliefs, and assumptions of management at the time of
such statements and are not guarantees of future performance.

The Company disclaims any obligations to update or revise any forward-looking
statement based on the occurrence of future events, the receipt of new
information or otherwise. Actual future performance, outcomes, and results may
differ materially from those expressed in forward-looking statements made by the
Company and its management as a result of a number of risks, uncertainties and
assumptions. Representative examples of these factors include (without
limitation) the impact of global pandemics, such as COVID-19; general industry
and economic conditions, including a decreasing number of national claims due to
a decreasing number of injured workers; competition from other managed care
companies and third party administrators; the ability to expand certain areas of
the Company's business; growth in the Company's sale of TPA services; shifts in
customer demands; the ability of the Company to produce market-competitive
software; changes in operating expenses including employee wages, benefits, and
medical inflation; cost of capital and capital requirements; dependence on key
personnel; the impact of possible cybersecurity incidents; existing and possible
litigation and legal liability in the course of operations and the Company's
ability to resolve such litigation; governmental and public policy changes,
including but not limited to legislative and administrative law and rule
implementation or change; the impact of recently issued accounting standards on
the Company's consolidated financial statements; the continued availability of
financing in the amounts and at the terms necessary to support the Company's
future business and the other risks identified in Part II, Item 1A of this
report.

Overview

CorVel Corporation is an independent nationwide provider of medical cost
containment and managed care services designed to address the escalating medical
costs of workers' compensation benefits, automobile insurance claims, and group
health insurance benefits. The Company's services are provided to insurance
companies, TPAs, governmental entities, and self-administered employers to
assist them in managing the medical costs and monitoring the quality of care
associated with healthcare claims. In November 2021, the Bureau of Labor
Statistics reported that the occupational injury and illness incidence rate for
2020 decreased by 5.7% from the prior year.

Patient Management Services

In addition to its network solutions services, the Company offers a range of
patient management services, which involve working one-on-one with injured
employees and their various healthcare professionals, employers and insurance
company adjusters. Patient management services include claims management and all
services sold to claims management customers, case management, 24/7 nurse
triage, utilization management, vocational rehabilitation, and life care
planning. The services are designed to monitor the medical necessity and
appropriateness of healthcare services provided to workers' compensation and
other healthcare claimants and to expedite return to work. The Company offers
these services on a stand-alone basis, or as an integrated component of its
medical cost containment services. Patient management services include the
processing of claims for self-insured payors with respect to property and
casualty insurance.

Network Solutions Services

The Company's network solutions services are designed to reduce the price paid
by its customers for medical services rendered in workers' compensation cases,
automobile insurance policies, and group health insurance policies. The network
solutions services offered by the Company include automated medical fee
auditing, preferred provider management and reimbursement services,
retrospective utilization review, facility claim review, professional review,
pharmacy services, directed care services, Medicare solutions, clearinghouse
services, independent medical examinations, and inpatient medical bill review.
Network solutions services also includes revenue from the Company's directed
care network (known as CareIQ), including imaging, physical therapy, durable
medical equipment, and translation and transportation.

                                    Page 18

--------------------------------------------------------------------------------

Organizational Structure

The Company's management is structured geographically with regional vice
presidents who are responsible for all services provided by the Company within
his or her particular region and responsible for the operating results of the
Company in multiple states. These regional vice presidents have area and
district managers who are also responsible for all services provided by the
Company in their given area and district.

Business Enterprise Segments

The Company operates in one reportable operating segment, managed care. The
Company's services are delivered to its customers through its local offices in
each region and financial information for the Company's operations follows this
service delivery model. All regions provide the Company's patient management and
network solutions services to customers. Financial Accounting Standards Board
("FASB") Accounting Standard Codification ("ASC") 280-10, "Segment Reporting",
establishes standards for the way that public business enterprises report
information about operating segments in annual and interim consolidated
financial statements. The Company's internal financial reporting is segmented
geographically, as discussed above, and managed on a geographic rather than
service line basis, with virtually all of the Company's operating revenue
generated within the United States.

Under FASB ASC 280-10, two or more operating segments may be aggregated into a
single operating segment for financial reporting purposes if aggregation is
consistent with the objective and basic principles, if the segments have similar
economic characteristics, and if the segments are similar in each of the
following areas: (i) the nature of products and services; (ii) the nature of the
production processes; (iii) the type or class of customer for their products and
services; and (iv) the methods used to distribute their products or provide
their services. The Company believes each of its regions meet these criteria as
each provides similar services and products to similar customers using similar
methods of production and distribution.

Because we believe we meet each of the criteria set forth above and each of our
regions have similar economic characteristics, we aggregate our results of
operations in one reportable operating segment, managed care.

Seasonality

While we are not directly impacted by seasonal shifts, we are affected by the
change in working days in a given quarter. There are generally fewer working
days for our employees to generate revenue in the third fiscal quarter due to
employee vacations, inclement weather, and holidays.

COVID-19 Pandemic

The economies of the United States and other countries around the world have
rapidly contracted as a result of the COVID-19 pandemic. The decreased level of
economic activity and uneven economic recovery is leading to, and is likely to
continue to lead to, a decline and/or volatility in exposure units and prolonged
and uneven unemployment. While the full impact of the COVID-19 pandemic cannot
be fully assessed at this time, the Company expects that the ongoing global
economic slowdown and uneven recovery resulting from the COVID-19 pandemic could
continue to have a material adverse effect on its business, results of
operations, financial condition, and cash flows in one or more future quarters.

The COVID-19 pandemic impacted our business, most significantly during the June
and September 2020 quarters. We implemented a 10% reduction in headcount that
began late in the March 2020 quarter and continued through the June 2020
quarter. We took actions intended to protect our employees and our customers
that adversely affected our results. We reduced discretionary spending,
including but not limited to cutting spending in planned capital expenditures,
travel, recruiting, consulting and temporary help expenses. We did not apply for
governmental loans to support our operations, but we have taken advantage of
certain aspects of the CARES Act such as the deferral of payroll tax deposits
through December 31, 2020. The Company paid back half the deferral of payroll
tax deposits during the December 31, 2021 quarter. The Company will pay back the
rest of payroll tax deposits during the December 31, 2022 quarter. The majority
of our workforce continues to work from home.

Summary of Quarterly Results

The Company's revenues increased to $164.5 million in the quarter ended December
31, 2021 from $141.5 million in the quarter ended December 31, 2020, an increase
of $23.0 million, or 16.3%. This increase was due to an increase in revenues in
patient management and network solutions services primarily as a result of the
economy recovering from the impact of the economic shutdown due to the COVID-19
pandemic in the United States that continued during the December 2020 quarter.
Most of the increase in revenues resulted primarily from an increase in activity
with existing customers and, to a lesser extent, an increase in new customers.

                                    Page 19

--------------------------------------------------------------------------------


Cost of revenues increased to $129.3 million in the quarter ended December 31,
2021 from $110.6 million in the quarter ended December 31, 2020, an increase of
$18.7 million, or 16.9%. This increase was primarily due to the increase of
16.3% in revenue mentioned above. Additionally, there was an increase in
salaries resulting from increased headcount of 15% in field operations.

General and administrative expense increased to $17.5 million in the quarter
ended December 31, 2021 from $16.9 million in the quarter ended December 31,
2020, an increase of $0.6 million, or 3.4%. This increase was primarily due to
an increase in marketing and software development costs in support of the
Company's proprietary systems.

Income tax expense increased to $3.8 million in the quarter ended December 31,
2021 from $2.6 million in the quarter ended December 31, 2020, an increase of
$1.2 million, or 48.4%. Income before income tax provision increased to $17.7
million in the quarter ended December 31, 2021 from $14.0 million in the quarter
ended December 31, 2020, an increase of $3.7 million, or 26.7%. The effective
tax rate was 21.6% for the quarter ended December 31, 2021 compared to 18.5% in
the quarter ended December 31, 2020.

Diluted weighted average common and common equivalent shares were 18.2 million
shares for the quarters ended December 31, 2021 and 2020. The weighted impact of
options exercised and the increased dilution impact of the outstanding options
offset the weighted impact of shares repurchased under the Company's stock
repurchase program.

Diluted earnings per share increased to $0.76 per share in the quarter ended
December 31, 2021 from $0.63 per share in the quarter ended December 31, 2020,
an increase of $0.13 per share, or 20.6%. The increase in diluted earnings per
share was primarily due to an increase in net income.

Results of Operations for the three months ended December 31, 2021 and 2020

The Company derives its revenues from providing patient management and network
solutions services to payors of workers' compensation benefits, automobile
insurance claims, and group health insurance benefits. The percentages of total
revenues attributable to patient management and network solutions services for
the quarters ended December 31, 2021 and 2020 are as follows:



                               December 31, 2021       December 31, 2020
Patient management services                  65.5 %                  68.2 %
Network solutions services                   34.5 %                  31.8 %




The following table sets forth, for the periods indicated, the dollar amounts,
dollar and percent changes, share changes, and the percentage of revenues
represented by certain items reflected in the Company's unaudited consolidated
income statements for the three months ended December 31, 2021 and 2020. The
Company's past operating results are not necessarily indicative of future
operating results.



                              Three Months Ended       Three Months Ended                       Percentage
                              December 31, 2021        December 31, 2020          Change          Change
Revenue                      $        164,508,000     $        141,506,000     $ 23,002,000            16.3 %
Cost of revenues                      129,320,000              110,613,000       18,707,000            16.9 %
Gross profit                           35,188,000               30,893,000        4,295,000            13.9 %
Gross profit as percentage
of revenue                                   21.4 %                   21.8 %
General and administrative             17,506,000               16,937,000          569,000             3.4 %
General and administrative
as percentage of
  revenue                                    10.6 %                   12.0 %
Income before income tax
provision                              17,682,000               13,956,000        3,726,000            26.7 %
Income before income tax
provision
  as percentage of revenue                   10.7 %                    9.9 %
Income tax provision                    3,824,000                2,576,000        1,248,000            48.4 %
Net income                   $         13,858,000     $         11,380,000     $  2,478,000            21.8 %
Weighted Average Shares
Basic                                  17,785,000               17,899,000         (114,000 )          (0.6 %)
Diluted                                18,211,000               18,180,000           31,000             0.2 %
Earnings Per Share
Basic                        $               0.78     $               0.64     $       0.14            21.9 %
Diluted                      $               0.76     $               0.63     $       0.13            20.6 %




                                    Page 20

--------------------------------------------------------------------------------

Revenues

Change in revenue to the quarter ended December 31, 2021 from the quarter ended
December 31, 2020

Revenues increased to $164.5 million in the quarter ended December 31, 2021 from
$141.5 million in the quarter ended December 31, 2020, an increase of $23.0
million, or 16.3%. Patient management services revenues increased to $107.7
million from $96.6 million, an increase of 11.6%. This increase is primarily due
to higher revenue from the Company's TPA and related services. Total new claims
increased by 6% during the December 31, 2021 quarter compared to the December
31, 2020 quarter. Network solutions services revenues increased to $56.8 million
from $45.0 million, an increase of 26.4%. This increase is primarily due to
increases in enhanced bill review programs services, which resulted in higher
revenue per bill. Most of the increase came from growth with existing customers
and, to a lesser extent, growth with new customers.





Cost of Revenues

The Company's cost of revenues consists of direct expenses, costs directly
attributable to the generation of revenue, and indirect costs which are incurred
to support the operations in the field offices which generate the revenue.
Direct expenses primarily include (i) case manager and bill review analysts'
salaries, along with related payroll taxes and fringe benefits, and (ii) costs
associated with independent medical examinations (known as IME), prescription
drugs, and MRI, physical therapy, and durable medical equipment providers. Most
of the Company's revenues are generated in offices which provide both patient
management services and network solutions services. The largest of the field
indirect costs are (i) manager salaries and bonuses, (ii) account executive base
pay and commissions, (iii) salaries of administrative and clerical support,
field systems personnel and PPO network developers, along with related payroll
taxes and fringe benefits, and (iv) office rent. Approximately 36% of the costs
incurred in the field are considered field indirect costs, which support both
the patient management services and network solutions operations of the
Company's field operations.

Change in cost of revenues to the quarter ended December 31, 2021 from the
quarter ended December 31, 2020

Cost of revenues increased to $129.3 million in the quarter ended December 31,
2021 from $110.6 million in the quarter ended December 31, 2020, an increase of
$18.7 million, or 16.9%. The increase in cost of revenues was primarily due to
the increase in total revenues of 16.3%. Additionally, there was an increase in
salaries resulting from increased headcount of 15% in field operations.
Headcount has increased due to an increase in new business and volume of
business.

General and Administrative Expense

For the quarter ended December 31, 2021, general and administrative expense
consisted of approximately 49% of corporate systems costs, which include the
corporate systems support, implementation and training, rules engine
development, national IT strategy and planning, depreciation of hardware costs
in the Company's corporate offices and backup data center, the Company's
nationwide area network, and other systems related costs. The Company includes
all IT-related costs managed by the corporate office in general and
administrative expense whereas the field IT-related costs are included in the
cost of revenues. The remaining general and administrative costs consist of
national marketing, national sales support, corporate legal, corporate
insurance, human resources, accounting, product management, new business
development, and other general corporate expenses.

Change in general and administrative expense to the quarter ended December 31,
2021 from the quarter ended December 31, 2020

General and administrative expense increased to $17.5 million in the quarter
ended December 31, 2021 from $16.9 million in the quarter ended December 31,
2020, an increase of $0.6 million, or 3.4%. This increase was primarily due to
an increase in advertising and corporate marketing events which are starting to
occur again in 2021 after being cancelled in 2020 due to the COVID-19 pandemic.
Additionally, software development costs also increased due to an increase in
headcount and consulting expenses.

Income Tax Provision

Change in income tax expense to the quarter ended December 31, 2021 from the
quarter ended December 31, 2020

Income tax expense increased to $3.8 million in the quarter ended December 31,
2021 from $2.6 million in the quarter ended December 31, 2020, an increase of
$1.2 million, or 48.4%. Income before income tax provision increased to $17.7
million in the quarter ended December 31, 2021 from $14.0 million in the quarter
ended December 31, 2020, an increase of $3.7 million, or 26.7%. The effective
tax rate was 21.6% for the quarter ended December 31, 2021 compared to 18.5% in
the quarter ended December 31, 2020. The effective tax rate is less than the
statutory tax rate primarily due to the impact of stock option exercises for
both periods.



                                    Page 21

--------------------------------------------------------------------------------

Results of Operations for the nine months ended December 31, 2021 and 2020

The following table sets forth, for the periods indicated, the dollar amounts,
dollar and percent changes, share changes, and the percentage of revenues
represented by certain items reflected in the Company's consolidated income
statements for the nine months ended December 31, 2021 and 2020. The Company's
past operating results are not necessarily indicative of future operating
results.



                              Nine Months Ended       Nine Months Ended                       Percentage
                              December 31, 2021       December 31, 2020         Change          Change
Revenue                      $       474,871,000     $       407,134,000     $ 67,737,000            16.6 %
Cost of revenues                     365,808,000             319,228,000       46,580,000            14.6 %
Gross profit                         109,063,000              87,906,000       21,157,000            24.1 %
Gross profit as percentage
of revenue                                  23.0 %                  21.6 %
General and administrative            50,810,000              48,084,000        2,726,000             5.7 %
General and administrative
as percentage of
  revenue                                   10.7 %                  11.8 %
Income before income tax
provision                             58,253,000              39,822,000       18,431,000            46.3 %
Income before income tax
provision as
  percentage of revenue                     12.3 %                   9.8 %
Income tax provision                  11,480,000               8,275,000        3,205,000            38.7 %
Net income                   $        46,773,000     $        31,547,000     $ 15,226,000            48.3 %
Weighted Average Shares
Basic                                 17,841,000              17,939,000          (98,000 )          (0.5 %)
Diluted                               18,221,000              18,156,000           65,000             0.4 %
Earnings Per Share
Basic                        $              2.62     $              1.76     $       0.86            48.9 %
Diluted                      $              2.57     $              1.74     $       0.83            47.7 %




                                    Page 22

--------------------------------------------------------------------------------

Revenues

Change in revenue to the nine months ended December 31, 2021 from the nine
months ended December 31, 2020

Revenues increased to $474.9 million for the nine months ended December 31, 2021
from $407.1 million for the nine months ended December 31, 2020, an increase of
$67.7 million, or 16.6%. Patient management services revenues increased to
$312.8 million from $272.0 million, an increase of 15.0%. This increase is
primarily due to higher revenue from the Company's TPA and related services.
Total new claims increased by 14% during the nine months ended December 31, 2021
compared to the nine months ended December 31, 2020. Network solutions services
revenues increased to $162.0 million from $135.1 million, an increase of 19.9%.
This increase is primarily due to increases in enhanced bill review program
services, which resulted in higher revenue per bill. Most of the increase came
from growth with existing customers and, to a lesser extent, growth with new
customers.

Cost of Revenues

Change in cost of revenues to the nine months ended December 31, 2021 from the
nine months ended December 31, 2020

Cost of revenues increased to $365.8 million in the nine months ended December
31, 2021 from $319.2 million in the nine months ended December 31, 2020, an
increase of $46.6 million, or 14.6%. The increase in cost of revenues was
primarily due to the increase in total revenues of 16.6%. Additionally, there
was an increase in salaries resulting from increased headcount of 15% in field
operations. Headcount has increased due to an increase in new business and
volume of business.

General and Administrative Expense

Change in administrative expense to the nine months ended December 31, 2021 from
the nine months ended December 31, 2020

General and administrative expense increased to $50.8 million in the nine months
ended December 31, 2021 from $48.1 million in the nine months ended December 31,
2020, an increase of $2.7 million, or 5.7%. This increase was primarily due to
an increase in advertising and corporate marketing events which are starting to
occur again in 2021 after being cancelled in 2020 due to the COVID-19 pandemic.
Additionally, software development costs also increased due to an increase in
headcount and consulting expenses.

Income Tax Provision

Change in income tax expense to the nine months ended December 31, 2021 from the
nine months ended December 31, 2020

Income tax expense increased to $11.5 million for the nine months ended December
31, 2021 from $8.3 million for the nine months ended December 31, 2020, an
increase of $3.2 million, or 38.7%. Income before income tax provision increased
to $58.3 million in the nine months ended December 31, 2021 from $39.8 million
in the nine months ended December 31, 2020, an increase of $18.4 million, or
46.3%. The income tax expense as a percentage of income before income taxes,
also known as the effective tax rate, was 19.8% for the nine months ended
December 31, 2021 and 21.0% for the nine months ended December 31, 2020. For the
nine months ended December 31, 2021, the effective tax rate is less than the
statutory tax rate primarily because of the impact of the stock option
exercises.

Liquidity and Capital Resources

The Company has historically funded its operations and capital expenditures
primarily from cash flow from operations, and to a lesser extent, proceeds from
stock option exercises. Working capital decreased to $98.1 million as of
December 31, 2021 from $106.5 million as of March 31, 2021, a decrease of $8.3
million. Cash decreased to $115.5 million as of December 31, 2021 from $139.7
million as of March 31, 2021, a decrease of $24.2 million. This is primarily due
to the increase in spending to repurchase shares of the Company's common stock.
The Company did not apply for governmental loans to support the Company's
operations, but has taken advantage of certain aspects of the CARES Act such as
the deferral of payroll tax deposits. The Company deferred a total of $10.4
million in payroll tax deposits, half of which was paid during the December 31,
2021 quarter, and the other half of which will be paid back by the end of
calendar year 2022.

                                    Page 23

--------------------------------------------------------------------------------


The Company believes that cash from operations and funds from exercises of stock
options granted to employees are adequate to fund existing obligations,
repurchase shares of the Company's common stock under its current stock
repurchase program, introduce new services, and continue to develop the
Company's healthcare related services for at least the next twelve months.
Should the Company have lower income or cash flows, it could reduce or eliminate
repurchases under the stock repurchase program until earnings and cash flow have
returned to comfortable levels. The Company regularly evaluates cash
requirements for current operations, commitments, capital acquisitions, and
other strategic transactions. The Company may elect to raise additional funds
for these purposes, through debt or equity financings or otherwise, as
appropriate. However, additional equity or debt financing may not be available
when needed, with terms favorable to the Company or at all.

As of December 31, 2021, the Company had $115.5 million in cash and cash
equivalents, invested primarily in short term, interest bearing, highly liquid
investment grade securities with maturities of 90 days or less.

The Company believes that the cash balance at December 31, 2021 along with
anticipated internally-generated funds will be sufficient to meet the Company's
expected cash requirements for at least the next twelve months.

Operating Activities

Nine months ended December 31, 2021 compared to nine months ended December 31,
2020

Net cash provided by operating activities decreased to $50.4 million in the nine
months ended December 31, 2021 from $73.8 million in the nine months ended
December 31, 2020, a decrease of $23.4 million. The decrease in cash flow from
operating activities was primarily due to the fact that the Company had a prior
year deferral of payroll taxes provided by the CARES Act in 2020 that was no
longer available during the same period in 2021. The Company paid back half of
the deferral of payroll taxes during the December 31, 2021 quarter.
Additionally, there was an increase in accounts receivable due to an increase in
revenues.



Investing Activities

Nine months ended December 31, 2021 compared to nine months ended December 31,
2020

Net cash flow used in investing activities increased to $18.4 million in the
nine months ended December 31, 2021 from $13.3 million in the nine months ended
December 31, 2020, an increase of $5.1 million. Capital purchases were $18.4
million for the nine months ended December 31, 2021 and $13.3 million for the
nine months ended December 31, 2020. The Company increased its spending
primarily on developed software and reduced its spending on furniture and
leasehold improvements as the Company reduces its lease footprint.

Financing Activities

Nine months ended December 31, 2021 compared to nine months ended December 31,
2020

Net cash flow used in financing activities increased to $56.1 million for the
nine months ended December 31, 2021 from $14.9 million for the nine months ended
December 31, 2020, an increase of $41.3 million. The increase in net cash used
in financing activities was primarily due to an increase in spending on share
repurchases to $65.3 million for the nine months ended December 31, 2021. The
Company spent $22.1 million on share repurchases for the nine months ended
December 31, 2020, when the stock repurchase program was temporarily suspended,
from March 21 through June 14, 2020, due to the COVID-19 pandemic.

Litigation

The Company is involved in litigation arising in the ordinary course of
business. Management believes that resolution of these matters will not result
in any payment that, individually or in the aggregate, would be material to the
financial position or results of operations of the Company.

Inflation

The Company experiences pricing pressures in the form of competitive prices. The
Company is also impacted by rising costs for certain inflation-sensitive
operating expenses such as labor, employee benefits, and facility leases.
However, the Company generally does not believe these impacts are material to
its revenues or net income.

Off-Balance Sheet Arrangements

The Company is not a party to off-balance sheet arrangements as defined by the
rules of the SEC. However, from time to time the Company enters into certain
types of contracts that contingently require the Company to indemnify parties
against third-party claims. The contracts primarily relate to: (i) certain
contracts to perform services, under which the Company may provide customary

                                    Page 24

--------------------------------------------------------------------------------


indemnification for the purchases of such services, (ii) certain real estate
leases, under which the Company may be required to indemnify property owners for
environmental and other liabilities, and other claims arising from the Company's
use of the applicable premises, and (iii) certain agreements with the Company's
officers, directors and employees, under which the Company may be required to
indemnify such persons for liabilities arising out of certain actions taken by
such persons, acting in their respective capacities within the Company.

The terms of such customary obligations vary by contract and in most instances a
specific or maximum dollar amount is not explicitly stated therein. Generally,
amounts under these contracts cannot be reasonably estimated until a specific
claim is asserted. Consequently, no material liabilities have been recorded for
these obligations on the Company's balance sheets for any of the periods
presented.

Critical Accounting Policies

The SEC defines critical accounting policies as those that require application
of management's most difficult, subjective, or complex judgments, often as a
result of the need to make estimates about the effect of matters that are
inherently uncertain and may change in subsequent periods.

The Company's significant accounting policies which have the greatest potential
impact on its financial statements are more fully described in the "Management's
Discussion and Analysis of Financial Condition and Results of Operations"
section of its Annual Report on Form 10-K for the fiscal year ended March 31,
2021, filed with the SEC on May 28, 2021. No changes in critical accounting
policies have been made since the filing of that Annual Report on Form 10-K.
Additional information related to adoption of accounting standards is provided
in Note 1 to the accompanying unaudited consolidated financial statements
contained in this Quarterly Report on Form 10-Q. In many cases, the accounting
treatment of a particular transaction is specifically dictated by accounting
principles generally accepted in the United States of America ("GAAP"), with no
need for management's judgment in their application. There are also areas in
which management's judgment in selecting an available alternative would not
produce a materially different result. Actual results could differ from the
estimates we use in applying our critical accounting policies. We are not
currently aware of any reasonably likely events or circumstances that would
result in materially different amounts being reported.

Recent Accounting Standards Update

See Note 1 - Summary of Significant Accounting Policies to the accompanying
unaudited consolidated financial statements contained elsewhere in this report
for information about recently issued and adopted accounting pronouncements.